The Vascular System in the Endometrium: Introduction and Overview

Peter A. W. Rogers, Caroline E. Gargett
In: Vascular Morphogenesis in the Female Reproductive System · 2001 · pp. 209–222 · doi:10.1007/978-1-4612-0213-4_11 · W17603754
book-chapter OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This section provides an overview of endometrial vascular structure and function during normal and pathological gynecologic conditions, detailing hormonal regulation and potential therapeutic targets.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-08 ⓘ

This paper provides an overview of how the endometrium’s vascular system is structured and regulated, covering physiologic angiogenesis and regression across growth, implantation, and menstruation, and discussing pathologic contexts such as endometriosis, menorrhagia, breakthrough bleeding, adenomyosis, and fibroids. It highlights the regulatory roles of estrogen and progesterone in endometrial vasculature and summarizes local factors involved in controlling blood vessel growth, stability, and function. It points to a rapidly increasing understanding of vessel regulation that could enable new therapies, including angiogenesis inhibitors and approaches targeting vessel stabilization to address bleeding and vessel fragility. The paper itself is an introduction/overview section rather than an original study, and it does not present new experimental results or specific limitations beyond its narrative scope. This paper is centrally about endometriosis — it specifically includes endometriosis as a pathologic context for endometrial vascular regulation and outlines angiogenesis-inhibitor strategies as a potential treatment direction.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The chapters in this section describe endometrial vascular structure and function, with particular emphasis on normal physiologic events such as growth, implantation, and menstruation, as well as pathologic situations such as endometriosis, menorrhagia, breakthrough bleeding, adenomyosis, and fibroids. The role that estrogen and progesterone play in regulating the endometrial vasculature during these processes is discussed, as are various other factors that regulate vascular function at a local level. The recent sudden increase in understanding of how blood vessel growth and regression is regulated, coupled with the major involvement of uterine vasculature in almost all clinically relevant gynecologic disorders, has opened exciting new possibilities for medical treatment. The challenge for scientists and clinicians working in this field will be to harness the promise that this knowledge brings to develop effective new therapies. Possible novel treatments that could be considered include use of angiogenesis inhibitors to prevent endometriosis, and vessel stabilization and maturation factors to reduce vessel fragility and breakthrough bleeding. The latest information in this rapidly developing field is detailed in the chapters in this section, with contributions from three of the leading groups currently working on different aspects of the regulation of endometrial vascular structure and function.

My notes (saved in your browser only)

Condition tags

endometriosisadenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (80)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK